What is Zhong Ji Longevity Science Group Sloan Ratio %?
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Jun. 2024, Zhong Ji Longevity Science Group has a Sloan Ratio of -6.92%, indicating the company is in the safe zone and there is no funny business with accruals.
Zhong Ji Longevity Science Group Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Zhong Ji Longevity Science Group Sloan Ratio % Chart
Competitive Comparison of Zhong Ji Longevity Science Group's Sloan Ratio %
For the Credit Services subindustry, Zhong Ji Longevity Science Group's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group's Sloan Ratio % Distribution in the Credit Services Industry
For the Credit Services industry and Financial Services sector, Zhong Ji Longevity Science Group's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's Sloan Ratio % falls into.
Zhong Ji Longevity Science Group Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group (HKSE:00767) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Jun. 2024, Zhong Ji Longevity Science Group has a Sloan Ratio of -6.92%, indicating the company is in the safe zone and there is no funny business with accruals.
Zhong Ji Longevity Science Group Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Zhong Ji Longevity Science Group's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Zhong Ji Longevity Science Group Business Description
Zhong Ji Longevity Science Group Ltd is an investment holding company. Through its subsidiaries, it engages in Longevity science business that provides diagnostic consultation, health and medical testing and checking as well as distribution of cancer prevention & immunity healthcare supplements, Money lending & Financial Advisory provides loan financing for earning interest income and provision of financial advisory and management services rendering various loans fees, Securities and other investments engages in holding of equity investments, investment in short to long-term financial assets for dividend income, and Property investment segment invests in properties for rental income and/or for potential capital appreciation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00767 has been successfully added to your 